This is a SOURCES SOUGHT NOTICE to determine the availability and capability of potential small businesses (including HUBZone firms; certified 8(a), Small Disadvantaged, veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. The U.S. Food and Drug Administration (FDA) is seeking capability statements from companies that are capable of providing an instrument based on Surface Plasmon Resonance.

Surface Plasmon Resonance instrument must meet the following specifications:
1. Sensitivity to measure kinetic parameters of analytes smaller than 3000 Dalton.
2. Sensitivity to detect and measure weak interactions, with KD in the mM range.
3. Ability to perform kinetic analysis from a single cycle.
4. Dedicated tools for immunogenicity testing of anti-drug antibodies.
5. Sample recovery in a small volume for identification by mass spectrometry.
6. Capacity to perform thermodynamic analysis.
7. Does not require labels to provide real-time data on the affinity, specificity and kinetics of molecular interactions.

The associated North American Industry Classification System (NAICS) Code is 334516 - Analytical Laboratory Instrument Manufacturing, Small Business Size Standard is 500 employees.

Interested offerors should submit their capability statement not exceeding fifteen (15) pages in length, excluding standard brochures. Potential contractors must indicate business size, proof of any set-aside certification and company's DUNS number and provide a contact name, the mailing address, phone number, email address of point of contact. Identification of the firm's GSA Schedule contract(s) by Schedule number and contract number and SINs that are applicable to this potential requirement are also requested. Capability statements must provide enough information to determine if the company can meet the requirement. At a minimum provide the following:
All descriptive material necessary for the government to determine whether the product offered meets the technical requirements including: technical specifications, descriptive material, literature, brochures and other information corresponding to each item, which demonstrates the capabilities of the contractor to meet the requirement.

Interested Contractors must respond with capability statements which are due in person, by postal mail, fax or email to the point of contact listed below on or before April 8, 2011 1:00 pm (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, Office of Acquisitions and Grants Services, Attn: Regina Williams, 3900 NCTR Road, HFT-320, Jefferson, AR 72079-9502. Reference solicitation number FDA1085716.

Disclaimer and Important Notes.
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)."

 

Bid Protests Not Available